Recruiting
Eczema nummular
RecruitingA study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
Registered drug
A study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
Registered drug
- Disease:Eczema nummular
- Substances:Lebrikizumab
Countries:
Bulgaria
Bulgaria- Participants:18–64 years · 65+ years
- Substances:Lebrikizumab
- Sponsor:Almirall S.A.



